
Pipeline
GTS currently offers a diverse range of cutting-edge oncology and autoimmune therapeutics crafted from nature's pharmacy. Nature has done the innovation; we have identified the biologically active compounds most viable to have therapeutic value. Each of our products represents a breakthrough in cancer treatment:
CTB-1
Our flagship product, CTB-1 is a groundbreaking compound primarily derived from cinnamon bark but can be found in other natural sources. It has been clinically proven to exhibit remarkable anti-cancer properties, selectively targeting malignant cells while also minimizing harm to healthy tissues. CTB-1 opens new avenues for treating various types of cancer with enhanced precision.
CTD-1
Another natural compound found from cinnamon bark that has proven clinical anti-cancer and autoimmune therapy properties. This versatile compound reinforces the body's natural defense mechanisms, bolstering the immune system and aiding in the fight against cancer and inflammatory conditions.